Induced Sputum Eicosanoid Concentrations in Asthma (Q55094021)

0 references

GERRIT WOLTMANN

0 references

ANDREW J. WARDLAW

0 references

JAMES R. SHELLER

0 references

RYSZARD DWORSKI

American Journal of Respiratory and Critical Care Medicine

0 references

language of work or name

English

0 references

publication date

December 1999

0 references

published in

0 references

volume

160

0 references

issue

0 references

page(s)

1905-1909

0 references

cites work

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

The use of induced sputum to investigate airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Allergic respiratory disease: strategic targets for primary prevention during childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

ICSH reference method for staining of blood and bone marrow films by azure B and eosin Y (Romanowsky stain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Statistics in respiratory medicine. 2. Repeatability and method comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Arachidonic acid metabolism. Implications of biological chemistry for lung function and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Bronchoprotective role for endogenous prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114

Effect of Inhaled Prostaglandin E2on Allergen-induced Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.160.6.9903114